{
    "biomarkers": {
        "REXQ5kwA": {
            "name": "FBN1",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "FBN1",
                "type": "DNA methylation biomarker",
                "description": "Fibrillin 1 gene associated with colorectal cancer (CRC)",
                "findings": "Shows differential methylation in CRC cases compared to controls",
                "notes": "Identified through DNA methylation analysis using EPIC arrays",
                "knowledge": [
                    {
                        "predicate": "shows differential methylation",
                        "object": "FBN1"
                    }
                ]
            }
        },
        "eaGQVHyu": {
            "name": "RBP4",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "RBP4",
                "type": "DNA methylation biomarker",
                "description": "Retinol-binding protein 4 gene associated with CRC",
                "findings": "Exhibits differential methylation patterns in CRC cases",
                "notes": "Part of a panel of methylation markers for CRC detection",
                "knowledge": [
                    {
                        "predicate": "exhibits differential methylation patterns",
                        "object": "RBP4"
                    }
                ]
            }
        },
        "G7dLuKPO": {
            "name": "C7orf10",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "C7orf10",
                "type": "DNA methylation biomarker",
                "description": "Chromosome 7 open reading frame 10 gene linked to CRC",
                "findings": "Demonstrates significant methylation changes in CRC",
                "notes": "Potential marker for early detection of CRC",
                "knowledge": [
                    {
                        "predicate": "demonstrates significant methylation changes",
                        "object": "C7orf10"
                    }
                ]
            }
        },
        "t18aZX5d": {
            "name": "TFPI2",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "TFPI2",
                "type": "DNA methylation biomarker",
                "description": "Tissue factor pathway inhibitor 2 gene associated with CRC",
                "findings": "Shows altered methylation in colorectal cancer tissues",
                "notes": "Correlates with clinical outcomes in CRC patients",
                "knowledge": [
                    {
                        "predicate": "shows altered methylation",
                        "object": "TFPI2"
                    }
                ]
            }
        },
        "BieyNlk3": {
            "name": "EPO",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "EPO",
                "type": "DNA methylation biomarker",
                "description": "Erythropoietin gene linked to CRC progression",
                "findings": "Exhibits hypermethylation in CRC cases",
                "notes": "Potential therapeutic target for CRC treatment",
                "knowledge": [
                    {
                        "predicate": "exhibits hypermethylation",
                        "object": "EPO"
                    }
                ]
            }
        },
        "O0fc9zAZ": {
            "name": "SLC6A20",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "SLC6A20",
                "type": "DNA methylation biomarker",
                "description": "Solute carrier family 6 member A20 gene associated with CRC",
                "findings": "Displays differential methylation in CRC cases compared to controls",
                "notes": "May play a role in CRC pathogenesis",
                "knowledge": [
                    {
                        "predicate": "displays differential methylation",
                        "object": "SLC6A20"
                    }
                ]
            }
        },
        "iFrwtSxR": {
            "name": "IRF1",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "IRF1",
                "type": "DNA methylation biomarker",
                "description": "Interferon regulatory factor 1 gene linked to CRC",
                "findings": "Shows significant methylation changes in CRC cases",
                "notes": "Involved in immune response and tumor suppression",
                "knowledge": [
                    {
                        "predicate": "shows significant methylation changes",
                        "object": "IRF1"
                    }
                ]
            }
        },
        "r-Px28_w": {
            "name": "Immunoglobulin G (IgG)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Immunoglobulin G (IgG)",
                "type": "glycoprotein",
                "description": "A type of antibody with specific glycosylation patterns.",
                "findings": "Increased levels in certain inflammatory conditions.",
                "notes": "Commonly studied for its role in immune responses and inflammation.",
                "knowledge": [
                    {
                        "predicate": "increased in",
                        "object": "inflammatory conditions"
                    }
                ]
            }
        },
        "43dBH509": {
            "name": "Immunoglobulin A (IgA)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Immunoglobulin A (IgA)",
                "type": "glycoprotein",
                "description": "Another class of antibody with distinct glycosylation.",
                "findings": "Varies in abundance and response compared to IgG.",
                "notes": "Important in mucosal immunity.",
                "knowledge": [
                    {
                        "predicate": "varies in",
                        "object": "abundance"
                    }
                ]
            }
        },
        "yTUePfdR": {
            "name": "Immunoglobulin M (IgM)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Immunoglobulin M (IgM)",
                "type": "glycoprotein",
                "description": "First antibody produced in response to an infection.",
                "findings": "Associated with a specific glycoform linked to certain diseases.",
                "notes": "Largest antibody, often indicative of recent infection.",
                "knowledge": [
                    {
                        "predicate": "linked to",
                        "object": "diseases"
                    }
                ]
            }
        },
        "UITiAXxs": {
            "name": "Haptoglobin (Hp)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Haptoglobin (Hp)",
                "type": "acute-phase protein",
                "description": "Binds free hemoglobin to prevent oxidative damage.",
                "findings": "Exists in two isoforms, Hp1 and Hp2, which are associated with different disease states.",
                "notes": "Used as a marker for hemolysis and inflammation.",
                "knowledge": [
                    {
                        "predicate": "associated with",
                        "object": "disease states"
                    }
                ]
            }
        },
        "6GQo62B9": {
            "name": "Transferrin (Tf)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Transferrin (Tf)",
                "type": "glycoprotein",
                "description": "Involved in iron transport and homeostasis.",
                "findings": "Shows specific glycan structures that are altered in chronic inflammation.",
                "notes": "Important for understanding iron metabolism disorders.",
                "knowledge": [
                    {
                        "predicate": "altered in",
                        "object": "chronic inflammation"
                    }
                ]
            }
        },
        "M5LUajuH": {
            "name": "Ceruloplasmin (Cp)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Ceruloplasmin (Cp)",
                "type": "ferroxidase enzyme",
                "description": "Involved in iron metabolism and antioxidant defense.",
                "findings": "Specific glycosylation patterns are associated with inflammatory conditions.",
                "notes": "Elevated levels are seen in acute-phase responses.",
                "knowledge": [
                    {
                        "predicate": "associated with",
                        "object": "inflammatory conditions"
                    }
                ]
            }
        },
        "-Wia-Af3": {
            "name": "Alpha-2 macroglobulin (A2M)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Alpha-2 macroglobulin (A2M)",
                "type": "protease inhibitor and cytokine transporter",
                "description": "A large plasma protein involved in immune regulation.",
                "findings": "Identified as a potential biomarker due to its glycosylation changes in inflammation.",
                "notes": "Plays a role in chronic inflammatory diseases.",
                "knowledge": [
                    {
                        "predicate": "changes in",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "0P46sg2C": {
            "name": "Fetuin-A",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Fetuin-A",
                "type": "glycoprotein",
                "description": "Inhibits calcification and regulates insulin activity.",
                "findings": "Levels are altered in certain inflammatory and metabolic conditions.",
                "notes": "Associated with cardiovascular diseases.",
                "knowledge": [
                    {
                        "predicate": "altered in",
                        "object": "inflammatory and metabolic conditions"
                    }
                ]
            }
        },
        "PN5rJ5Jr": {
            "name": "Albumin",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Albumin",
                "type": "plasma protein",
                "description": "Most abundant plasma protein, not a glycoprotein.",
                "findings": "Levels decrease in chronic inflammatory states due to capillary leakage.",
                "notes": "Common marker for nutritional status and liver function.",
                "knowledge": [
                    {
                        "predicate": "decrease in",
                        "object": "chronic inflammation"
                    }
                ]
            }
        },
        "PAi1eEaO": {
            "name": "C-reactive protein (CRP)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "C-reactive protein (CRP)",
                "type": "acute-phase reactant",
                "description": "Produced in response to inflammation.",
                "findings": "Levels increase significantly during bacterial infections and inflammatory conditions.",
                "notes": "Commonly used as a clinical marker for infection and inflammation.",
                "knowledge": [
                    {
                        "predicate": "increase in",
                        "object": "bacterial infections"
                    }
                ]
            }
        },
        "nzefFjV1": {
            "name": "Serum Amyloid A (SAA)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Serum Amyloid A (SAA)",
                "type": "acute-phase protein",
                "description": "Increases rapidly in response to inflammation.",
                "findings": "Levels are elevated in chronic inflammatory conditions.",
                "notes": "Associated with amyloidosis and various infections.",
                "knowledge": [
                    {
                        "predicate": "elevated in",
                        "object": "chronic inflammation"
                    }
                ]
            }
        },
        "2L6SQsPx": {
            "name": "Amyloid A",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Amyloid A",
                "type": "protein precursor to amyloid fibrils",
                "description": "Associated with chronic inflammatory conditions and certain cancers.",
                "findings": "Linked to disease states through specific glycosylation patterns.",
                "notes": "Implicated in the pathogenesis of amyloidosis.",
                "knowledge": [
                    {
                        "predicate": "linked to",
                        "object": "disease states"
                    }
                ]
            }
        },
        "zxPfLT9I": {
            "name": "Lipoproteins (e.g., LDL, HDL)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Lipoproteins (e.g., LDL, HDL)",
                "type": "lipid transport proteins",
                "description": "Responsible for cholesterol and lipid transport.",
                "findings": "Show altered glycosylation patterns in metabolic disorders.",
                "notes": "Associated with cardiovascular diseases.",
                "knowledge": [
                    {
                        "predicate": "altered in",
                        "object": "metabolic disorders"
                    }
                ]
            }
        },
        "Ydbi7ycM": {
            "name": "miR-126",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "miR-126",
                "type": "microRNA (miRNA)",
                "description": "A microRNA expressed in colorectal cancer exosomes (CEx) with potential as a diagnostic and prognostic biomarker.",
                "findings": "Reported as a potential biomarker for early CRC diagnosis and prognosis with robust predictive results.",
                "notes": "Part of a proposed CEx-miRNAs panel for minimally invasive CRC detection.",
                "knowledge": [
                    {
                        "predicate": "reported as a potential biomarker",
                        "object": "miR-126"
                    },
                    {
                        "predicate": "showed robust predictive results",
                        "object": "miR-126"
                    }
                ]
            }
        },
        "iHOuGilg": {
            "name": "miR-1290",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "miR-1290",
                "type": "microRNA (miRNA)",
                "description": "A microRNA associated with colorectal cancer exosomes and tumor progression.",
                "findings": "Identified as a potential biomarker for early CRC diagnosis and prognosis with strong predictive data.",
                "notes": "Included in the proposed panel of CEx-miRNAs for early CRC detection.",
                "knowledge": [
                    {
                        "predicate": "identified as a potential biomarker",
                        "object": "miR-1290"
                    },
                    {
                        "predicate": "showed strong predictive data",
                        "object": "miR-1290"
                    }
                ]
            }
        },
        "T_92-2zV": {
            "name": "miR-23a",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "miR-23a",
                "type": "microRNA (miRNA)",
                "description": "A microRNA linked to colorectal cancer progression and metastasis.",
                "findings": "Associated with tumor progression and angiogenesis in CRC.",
                "notes": "Part of the proposed panel for CEx-miRNAs-based early CRC detection.",
                "knowledge": [
                    {
                        "predicate": "associated with tumor progression",
                        "object": "miR-23a"
                    },
                    {
                        "predicate": "linked to angiogenesis in CRC",
                        "object": "miR-23a"
                    }
                ]
            }
        },
        "XU9l9wlC": {
            "name": "miR-940",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "miR-940",
                "type": "microRNA (miRNA)",
                "description": "A microRNA found in colorectal cancer exosomes with diagnostic potential.",
                "findings": "Associated with CRC pathogenesis and proposed as a non-invasive biomarker.",
                "notes": "Included in the panel of CEx-miRNAs for early CRC detection.",
                "knowledge": [
                    {
                        "predicate": "associated with CRC pathogenesis",
                        "object": "miR-940"
                    },
                    {
                        "predicate": "proposed as a non-invasive biomarker",
                        "object": "miR-940"
                    }
                ]
            }
        },
        "Jzl-MUqX": {
            "name": "MSI-H",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "MSI-H",
                "type": "Microsatellite Instability Status",
                "description": "A condition where there is a failure of the DNA mismatch repair system, leading to genomic instability.",
                "findings": " MSI-H status is predictive of response to immune checkpoint inhibitors (ICIs) and confers improved clinical outcomes with reduced toxicities.",
                "notes": "Identified as a key biomarker for immunotherapy in colorectal cancer.",
                "knowledge": [
                    {
                        "predicate": "predictive of response",
                        "object": "immune checkpoint inhibitors (ICIs)"
                    },
                    {
                        "predicate": "confers improved clinical outcomes with reduced toxicities",
                        "object": "patients"
                    }
                ]
            }
        },
        "yI5r_NUw": {
            "name": "BRAF V600E mutation",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "BRAF V600E mutation",
                "type": "Gene Mutation",
                "description": "A specific mutation in the BRAF gene, known to be oncogenic.",
                "findings": "BRAF V600E mutation is a negative prognostic marker but predicts response to combined targeted BRAF/EGFR inhibition, doubling survival over standard treatments.",
                "notes": "Commonly found in colorectal cancers with poor prognosis if untreated appropriately.",
                "knowledge": [
                    {
                        "predicate": "negative prognostic value",
                        "object": "patients"
                    },
                    {
                        "predicate": "predicts response to combined targeted BRAF/EGFR inhibition",
                        "object": "targeted therapy"
                    }
                ]
            }
        },
        "ybfBEAgf": {
            "name": "RAS mutation",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "RAS mutation",
                "type": "Gene Mutation",
                "description": "Mutations in the RAS gene family are associated with resistance to certain therapies.",
                "findings": "RAS mutations are predictive of resistance to anti-EGFR therapies.",
                "notes": "Commonly used as a marker to guide treatment decisions in colorectal cancer.",
                "knowledge": [
                    {
                        "predicate": "predictive of resistance",
                        "object": "anti-EGFR therapies"
                    }
                ]
            }
        },
        "Or8Jzu-0": {
            "name": "HLA-A*03 allele",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "HLA-A*03 allele",
                "type": "Human Leukocyte Antigen Allele",
                "description": "A specific allele of the HLA-A gene, which plays a role in immune recognition.",
                "findings": "HLA-A*03 allele may predict clinical benefit with nivolumab and ipilimumab combination therapy.",
                "notes": "Emerging as a potential predictive marker for immunotherapy responses.",
                "knowledge": [
                    {
                        "predicate": "may predict clinical benefit",
                        "object": "nivolumab and ipilimumab combination therapy"
                    }
                ]
            }
        },
        "_QFeeTYV": {
            "name": "HER2 amplification",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "HER2 amplification",
                "type": "Gene Amplification",
                "description": "An increase in the number of HER2 gene copies, often associated with cancer progression.",
                "findings": "HER2 amplification is a potential target for anti-HER2 therapies.",
                "notes": "Less common but relevant in certain colorectal cancer cases.",
                "knowledge": [
                    {
                        "predicate": "potential target",
                        "object": "anti-HER2 therapies"
                    }
                ]
            }
        },
        "3lzVLq-K": {
            "name": "HLA-B*15 and HLA-B*35 alleles",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "HLA-B*15 and HLA-B*35 alleles",
                "type": "Human Leukocyte Antigen Alleles",
                "description": "Specific alleles of the HLA-B gene associated with immune responses.",
                "findings": "HLA-B*15 and HLA-B*35 alleles are associated with improved overall survival in patients treated with nivolumab and ipilimumab combination therapy.",
                "notes": "Emerging biomarkers for immunotherapy response prediction.",
                "knowledge": [
                    {
                        "predicate": "associated with improved overall survival",
                        "object": "nivolumab and ipilimumab combination therapy"
                    }
                ]
            }
        },
        "5LiJJST2": {
            "name": "KRAS mutation",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "KRAS mutation",
                "type": "Gene Mutation",
                "description": "A mutation in the KRAS gene, commonly implicated in cancer.",
                "findings": "KRAS mutations are associated with susceptibility to ferroptosis and may serve as a predictive marker for therapies targeting this pathway.",
                "notes": "Frequently mutated in colorectal cancers; potential role in novel therapeutic approaches.",
                "knowledge": [
                    {
                        "predicate": "associated with susceptibility",
                        "object": "ferroptosis"
                    }
                ]
            }
        },
        "7mbQb49v": {
            "name": "MMR/MSI",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "MMR/MSI",
                "type": "Mismatch Repair/Microsatellite Instability Status",
                "description": "A condition where there is a failure of the DNA mismatch repair system, leading to genomic instability.",
                "findings": "MMR/MSI status is predictive of response to immunotherapy and other targeted therapies in colorectal cancer.",
                "notes": "Closely related to MSI-H status; often used interchangeably in clinical contexts.",
                "knowledge": [
                    {
                        "predicate": "predictive of response",
                        "object": "immunotherapy"
                    }
                ]
            }
        },
        "GSoTGG8o": {
            "name": "Ki-67",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Ki-67",
                "type": "Proliferation marker",
                "description": "A nuclear protein that is expressed in all active phases of the cell cycle (G1, S, G2, and mitosis), but not in resting cells (G0). It is commonly used as a marker for cell proliferation.",
                "findings": "Overexpression of Ki-67 has been associated with worse clinical outcomes in various cancers, including breast cancer.",
                "notes": "Ki-67 expression levels are often assessed via immunohistochemistry in tumor samples to determine the growth fraction of cells.",
                "knowledge": [
                    {
                        "predicate": "is a proliferation marker",
                        "object": "Ki-67"
                    },
                    {
                        "predicate": "overexpression is associated with worse clinical outcomes",
                        "object": "breast cancer"
                    }
                ]
            }
        },
        "CzgYy270": {
            "name": "HER2",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "HER2",
                "type": "Receptor tyrosine kinase",
                "description": "Human epidermal growth factor receptor 2 (HER2) is a gene that can play a role in the development of breast cancer. When overexpressed, it is associated with aggressive tumor behavior.",
                "findings": "Amplification or overexpression of HER2 is found in approximately 20% of early-stage breast cancers and is associated with increased tumor aggressiveness and reduced survival rates if untreated.",
                "notes": "HER2 status is determined through immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH). HER2-positive cancers are eligible for targeted therapies such as trastuzumab.",
                "knowledge": [
                    {
                        "predicate": "is a receptor tyrosine kinase",
                        "object": "HER2"
                    },
                    {
                        "predicate": "overexpression is associated with aggressive tumor behavior",
                        "object": "breast cancer"
                    }
                ]
            }
        },
        "gbImgwnj": {
            "name": "p53",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "p53",
                "type": "Tumor suppressor protein",
                "description": "The p53 gene produces a protein that plays a crucial role in regulating the cell cycle, preventing cells with damaged DNA from dividing. Mutations in p53 can lead to uncontrolled cell growth and cancer.",
                "findings": "Mutations in the p53 gene are found in approximately 50% of human cancers, including colorectal, breast, and lung cancers. These mutations often correlate with poor prognosis and increased metastatic potential.",
                "notes": "p53 mutations can lead to loss of normal tumor suppressor function, resulting in unchecked cell proliferation.",
                "knowledge": [
                    {
                        "predicate": "is a tumor suppressor protein",
                        "object": "p53"
                    },
                    {
                        "predicate": "mutations are associated with poor prognosis",
                        "object": "colorectal cancer"
                    }
                ]
            }
        },
        "eHJ8YL49": {
            "name": "ER (Estrogen Receptor)",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "ER (Estrogen Receptor)",
                "type": "Steroid hormone receptor",
                "description": "The estrogen receptor (ER) is a protein that binds to the hormone estrogen. In breast cancer, ER positivity indicates that cancer cells may respond to endocrine therapies.",
                "findings": "Approximately 70-80% of breast cancers are ER-positive, meaning they express high levels of the ER protein. ER-positive tumors tend to grow slower and are more likely to respond to hormone therapy.",
                "notes": "ER status is determined through immunohistochemistry (IHC). Positive ER status is associated with improved survival rates when treated with endocrine therapies such as tamoxifen or aromatase inhibitors.",
                "knowledge": [
                    {
                        "predicate": "is a steroid hormone receptor",
                        "object": "ER"
                    },
                    {
                        "predicate": "positivity indicates potential response to endocrine therapies",
                        "object": "breast cancer"
                    }
                ]
            }
        },
        "Qjua7Sm_": {
            "name": "PR (Progesterone Receptor)",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "PR (Progesterone Receptor)",
                "type": "Steroid hormone receptor",
                "description": "The progesterone receptor (PR) is a protein that binds to the hormone progesterone. In breast cancer, PR positivity often indicates a favorable prognosis and responsiveness to hormone therapies.",
                "findings": "PR-positive breast cancers are more likely to respond to endocrine therapies. The presence of PR often correlates with ER positivity, as both receptors are regulated by estrogen.",
                "notes": "PR status is also determined through immunohistochemistry (IHC). Positive PR status is generally associated with better clinical outcomes in breast cancer patients.",
                "knowledge": [
                    {
                        "predicate": "is a steroid hormone receptor",
                        "object": "PR"
                    },
                    {
                        "predicate": "positivity indicates favorable prognosis",
                        "object": "breast cancer"
                    }
                ]
            }
        },
        "fMdEwTrT": {
            "name": "guanylate cyclase-C (GUCY2C)",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "guanylate cyclase-C (GUCY2C)",
                "type": "protein biomarker",
                "description": "A protein expressed in colorectal cancer cells but not in normal tissues.",
                "findings": "Expression of GUCY2C is associated with metastatic colorectal cancer and serves as a target for chimeric antigen receptor (CAR) T-cell therapy. High expression levels may correlate with better treatment outcomes.",
                "notes": "GUCY2C immunohistochemistry was used to confirm its expression in tumor tissues.",
                "knowledge": [
                    {
                        "predicate": "is expressed in",
                        "object": "colorectal cancer cells"
                    },
                    {
                        "predicate": "serves as a target for",
                        "object": "CAR T-cell therapy"
                    },
                    {
                        "predicate": "expression levels may correlate with",
                        "object": "better treatment outcomes"
                    }
                ]
            }
        },
        "2EGEM5wO": {
            "name": "GUCY2C immunohistochemistry",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "GUCY2C immunohistochemistry",
                "type": "assay biomarker",
                "description": "A method to detect the expression of GUCY2C protein in tissues.",
                "findings": "Used to confirm GUCY2C expression in tumor tissues, aiding in patient selection for targeted therapies.",
                "notes": "This assay helps identify patients who may benefit from GUCY2C-targeted treatments.",
                "knowledge": [
                    {
                        "predicate": "is used to detect",
                        "object": "GUCY2C protein expression"
                    },
                    {
                        "predicate": "aids in",
                        "object": "patient selection for targeted therapies"
                    }
                ]
            }
        },
        "LZbjQsPr": {
            "name": "hCRISPRs",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "hCRISPRs",
                "type": "Endogenous CRISPR-Cas systems",
                "description": "Human CRISPR sequences (hCRISPRs) are endogenous CRISPR-Cas systems found in the human genome.",
                "findings": "hCRISPRs can be used as biosensors for SARS-CoV-2 detection. They are more stable and abundant compared to exogenous CRISPR systems, making them suitable for diagnostic applications.",
                "notes": "hCRISPRs were tested using SHERLOCK and DETECTR technologies.",
                "knowledge": [
                    {
                        "predicate": "used with SHERLOCK technology",
                        "object": "SARS-CoV-2 detection"
                    },
                    {
                        "predicate": "tested using DETECTR technology",
                        "object": "diagnostic applications"
                    }
                ]
            }
        },
        "4m2oE7eE": {
            "name": "CRISPR-Cas systems",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "CRISPR-Cas systems",
                "type": "Biosensor",
                "description": "CRISPR-Cas systems are being explored for their potential as biosensors in diagnostics.",
                "findings": "Endogenous CRISPR-Cas systems like hCRISPRs show promise for detecting pathogens such as SARS-CoV-2 due to their stability and abundance.",
                "notes": "hCRISPRs are a subset of CRISPR-Cas systems found in the human genome.",
                "knowledge": [
                    {
                        "predicate": "show promise for detecting",
                        "object": "SARS-CoV-2"
                    },
                    {
                        "predicate": "due to their stability and abundance",
                        "object": "pathogen detection"
                    }
                ]
            }
        },
        "dSTX7n9z": {
            "name": "Acetone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Acetone",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A compound with an abnormal fruity odor, potentially used as a biomarker for cancer.",
                "findings": "Acetone concentration in breath changes during activities such as exercising or fasting, limiting its reliability as a standalone biomarker. It is considered an adequate cancer biomarker but not appropriate due to variability.",
                "notes": "Acetone levels are influenced by physical activities and metabolic states.",
                "knowledge": [
                    {
                        "predicate": "is a potential biomarker for",
                        "object": "cancer"
                    },
                    {
                        "predicate": "has concentration variations during",
                        "object": "exercising or fasting"
                    }
                ]
            }
        },
        "9iP8Qgnh": {
            "name": "4-Heptanone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "4-Heptanone",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A compound with unclear origins, limiting its use as a biomarker.",
                "findings": "The origin of 4-heptanone is unclear, making it unsuitable as a reliable biomarker for cancer.",
                "notes": "Its unclear origins limit its utility in cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "origin is",
                        "object": "unclear"
                    },
                    {
                        "predicate": "is not recommended as a biomarker due to",
                        "object": "unclear origins"
                    }
                ]
            }
        },
        "5ab9h0JR": {
            "name": "Ethanol",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Ethanol",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A common VOC potentially linked to cancer metabolism.",
                "findings": "Ethanol is mentioned as a VOC related to cancer metabolism but no specific findings are detailed in the article.",
                "notes": "Limited information provided on its role in cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "is related to",
                        "object": "cancer metabolism"
                    }
                ]
            }
        },
        "WPQiC9cL": {
            "name": "Methanol",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Methanol",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC potentially associated with cancer metabolism.",
                "findings": "Methanol is mentioned as a VOC related to cancer metabolism but no specific findings are detailed in the article.",
                "notes": "Limited information provided on its role in cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "is related to",
                        "object": "cancer metabolism"
                    }
                ]
            }
        },
        "JuAE9BiN": {
            "name": "Formaldehyde",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Formaldehyde",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC potentially linked to cancer metabolism.",
                "findings": "Formaldehyde is mentioned as a VOC related to cancer metabolism but no specific findings are detailed in the article.",
                "notes": "Limited information provided on its role in cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "is related to",
                        "object": "cancer metabolism"
                    }
                ]
            }
        },
        "7pTWcOf8": {
            "name": "Acetaldehyde",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Acetaldehyde",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC potentially associated with cancer metabolism.",
                "findings": "Acetaldehyde is mentioned as a VOC related to cancer metabolism but no specific findings are detailed in the article.",
                "notes": "Limited information provided on its role in cancer diagnostics.",
                "knowledge": [
                    {
                        "predicate": "is related to",
                        "object": "cancer metabolism"
                    }
                ]
            }
        },
        "NgbAhP1h": {
            "name": "Propanal",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Propanal",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC with higher concentrations in gastric cancer patients.",
                "findings": "Propanal has higher concentrations in the breath of gastric cancer patients compared to healthy individuals.",
                "notes": "May be a specific marker for gastric cancer.",
                "knowledge": [
                    {
                        "predicate": "has higher concentrations in",
                        "object": "gastric cancer patients"
                    }
                ]
            }
        },
        "BLvF5Hp8": {
            "name": "Pentanal",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Pentanal",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC with higher concentrations in gastric cancer patients.",
                "findings": "Pentanal has higher concentrations in the breath of gastric cancer patients compared to healthy individuals.",
                "notes": "May be a specific marker for gastric cancer.",
                "knowledge": [
                    {
                        "predicate": "has higher concentrations in",
                        "object": "gastric cancer patients"
                    }
                ]
            }
        },
        "MPwQtUrY": {
            "name": "Hexanal",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Hexanal",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC linked to lipid peroxidation, elevated in colorectal cancer.",
                "findings": "Hexanal is associated with lipid peroxidation and has been found in higher concentrations in colorectal cancer patients.",
                "notes": "May be a marker for colorectal cancer.",
                "knowledge": [
                    {
                        "predicate": "is linked to",
                        "object": "lipid peroxidation"
                    },
                    {
                        "predicate": "has higher concentrations in",
                        "object": "colorectal cancer patients"
                    }
                ]
            }
        },
        "k_636IXh": {
            "name": "Heptanal",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Heptanal",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC linked to lipid peroxidation, elevated in colorectal cancer.",
                "findings": "Heptanal is associated with lipid peroxidation and has been found in higher concentrations in colorectal cancer patients.",
                "notes": "May be a marker for colorectal cancer.",
                "knowledge": [
                    {
                        "predicate": "is linked to",
                        "object": "lipid peroxidation"
                    },
                    {
                        "predicate": "has higher concentrations in",
                        "object": "colorectal cancer patients"
                    }
                ]
            }
        },
        "S9GMyI7y": {
            "name": "1-Penten-3-one",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "1-Penten-3-one",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A VOC potentially associated with both gastric and colorectal cancers.",
                "findings": "1-Penten-3-one is found in the breath of both gastric and colorectal cancer patients but is not specific to these cancers alone.",
                "notes": "May be a general marker for various cancers but lacks specificity.",
                "knowledge": [
                    {
                        "predicate": "is found in",
                        "object": "gastric and colorectal cancer patients"
                    },
                    {
                        "predicate": "lacks specificity for",
                        "object": "cancer diagnosis"
                    }
                ]
            }
        },
        "0ltG9MQD": {
            "name": "Faecalibacterium",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Faecalibacterium",
                "type": "microbial genus",
                "description": "A genus of bacteria known for its role in gut health and inflammation reduction.",
                "findings": "Significantly reduced abundance in colorectal cancer (CRC) patients compared to healthy controls, suggesting a protective role against CRC.",
                "notes": "Faecalibacterium is a key butyrate-producing bacterium, which has anti-inflammatory properties.",
                "knowledge": [
                    {
                        "predicate": "is significantly reduced in CRC",
                        "object": "Faecalibacterium"
                    },
                    {
                        "predicate": "plays a protective role against CRC",
                        "object": "Faecalibacterium"
                    }
                ]
            }
        },
        "Q5D0kkny": {
            "name": "Fusobacterium",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Fusobacterium",
                "type": "microbial genus",
                "description": "A genus of bacteria associated with various infections and inflammatory conditions.",
                "findings": "Significantly higher abundance in CRC patients compared to healthy controls, suggesting a potential role in CRC development or progression.",
                "notes": "Fusobacterium is known for its pro-inflammatory properties and has been implicated in colorectal carcinogenesis.",
                "knowledge": [
                    {
                        "predicate": "is significantly higher in CRC",
                        "object": "Fusobacterium"
                    },
                    {
                        "predicate": "may contribute to CRC development or progression",
                        "object": "Fusobacterium"
                    }
                ]
            }
        },
        "RZ0uh9V7": {
            "name": "Roseburia",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Roseburia",
                "type": "microbial genus",
                "description": "A genus of bacteria known for producing butyrate, a short-chain fatty acid with anti-inflammatory properties.",
                "findings": "Significantly reduced abundance in CRC patients compared to healthy controls, suggesting a protective role against CRC.",
                "notes": "Roseburia is a key butyrate-producing bacterium, which has anti-inflammatory properties.",
                "knowledge": [
                    {
                        "predicate": "is significantly reduced in CRC",
                        "object": "Roseburia"
                    },
                    {
                        "predicate": "plays a protective role against CRC",
                        "object": "Roseburia"
                    }
                ]
            }
        },
        "uuLxKhe8": {
            "name": "Parabacteroides",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Parabacteroides",
                "type": "microbial genus",
                "description": "A genus of bacteria commonly found in the human gut microbiota.",
                "findings": "Significantly reduced abundance in CRC patients compared to healthy controls, suggesting a potential protective role against CRC.",
                "notes": "Parabacteroides is associated with gut health and may play a role in maintaining the balance of the gut microbiota.",
                "knowledge": [
                    {
                        "predicate": "is significantly reduced in CRC",
                        "object": "Parabacteroides"
                    },
                    {
                        "predicate": "may have a protective role against CRC",
                        "object": "Parabacteroides"
                    }
                ]
            }
        },
        "WqLn3GBP": {
            "name": "Bifidobacterium",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Bifidobacterium",
                "type": "microbial genus",
                "description": "A genus of bacteria known for its probiotic properties and role in gut health.",
                "findings": "Significantly reduced abundance in CRC patients compared to healthy controls, suggesting a potential protective role against CRC.",
                "notes": "Bifidobacterium is associated with gut health and may play a role in maintaining the balance of the gut microbiota.",
                "knowledge": [
                    {
                        "predicate": "is significantly reduced in CRC",
                        "object": "Bifidobacterium"
                    },
                    {
                        "predicate": "may have a protective role against CRC",
                        "object": "Bifidobacterium"
                    }
                ]
            }
        },
        "n4wS4SDO": {
            "name": "Blautia",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Blautia",
                "type": "microbial genus",
                "description": "A genus of bacteria commonly found in the human gut microbiota.",
                "findings": "Significantly reduced abundance in CRC patients compared to healthy controls, suggesting a potential protective role against CRC.",
                "notes": "Blautia is associated with gut health and may play a role in maintaining the balance of the gut microbiota.",
                "knowledge": [
                    {
                        "predicate": "is significantly reduced in CRC",
                        "object": "Blautia"
                    },
                    {
                        "predicate": "may have a protective role against CRC",
                        "object": "Blautia"
                    }
                ]
            }
        },
        "QOU7Iikg": {
            "name": "Acetone",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Acetone",
                "type": "Ketone",
                "description": "A secondary product of lipid peroxidation, often associated with metabolic conditions involving high oxidation rates of fatty acids.",
                "findings": "Elevated levels in CRC patients' breath samples, identified via GC-MS analysis.",
                "notes": "Commonly associated with ketosis but also linked to oxidative stress in cancer contexts.",
                "knowledge": [
                    {
                        "predicate": "elevated in CRC patients",
                        "object": "Acetone"
                    }
                ]
            }
        },
        "366cL3J0": {
            "name": "Alkenes",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Alkenes",
                "type": "Hydrocarbons",
                "description": "Unsaturated hydrocarbons with at least one double bond, often produced as byproducts of oxidative stress.",
                "findings": "Detected in breath samples of CRC patients; linked to oxidative stress mechanisms.",
                "notes": "Common biomarkers for oxidative stress-related conditions.",
                "knowledge": [
                    {
                        "predicate": "linked to oxidative stress",
                        "object": "Alkenes"
                    }
                ]
            }
        },
        "4iIcODEi": {
            "name": "Alcohols",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Alcohols",
                "type": "Oxygen-containing organic compounds",
                "description": "Primarily derived from food, alcohol beverages, or metabolism of hydrocarbons by cytochrome p450 enzymes.",
                "findings": "Present in breath samples, potentially indicating metabolic activity related to CRC.",
                "notes": "Can originate from dietary sources or metabolic processes.",
                "knowledge": [
                    {
                        "predicate": "derived from food and alcohol metabolism",
                        "object": "Alcohols"
                    }
                ]
            }
        },
        "aKIHtrqz": {
            "name": "Ketones",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Ketones",
                "type": "Organic compounds with a carbonyl group",
                "description": "Include acetone, which is associated with lipid peroxidation and oxidative stress.",
                "findings": "Elevated levels of ketones like acetone found in CRC patients' breath samples.",
                "notes": "Ketones are often markers of metabolic states such as ketosis.",
                "knowledge": [
                    {
                        "predicate": "elevated in CRC patients",
                        "object": "Ketones"
                    }
                ]
            }
        },
        "qAPTAqKt": {
            "name": "Esters",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Esters",
                "type": "Organic compounds with a carbonyl group",
                "description": "Commonly found in natural sources like fats, oils, and waxes; also present in breath samples.",
                "findings": "Detected in CRC patients' breath samples via GC-MS analysis.",
                "notes": "Their role in CRC is less clear but may relate to metabolic byproducts.",
                "knowledge": [
                    {
                        "predicate": "detected in CRC patients",
                        "object": "Esters"
                    }
                ]
            }
        },
        "TO187V5F": {
            "name": "Hydrocarbons",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Hydrocarbons",
                "type": "Organic compounds consisting of hydrogen and carbon",
                "description": "Produced as byproducts of oxidative stress, with alkenes being a specific subset.",
                "findings": "Altered levels in CRC patients' breath samples linked to oxidative stress mechanisms.",
                "notes": "Hydrocarbons like alkanes and alkenes are markers of oxidative processes.",
                "knowledge": [
                    {
                        "predicate": "linked to oxidative stress",
                        "object": "Hydrocarbons"
                    }
                ]
            }
        },
        "GW_kDZTp": {
            "name": "Reactive Oxygen Species (ROS)",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "Reactive Oxygen Species (ROS)",
                "type": "Highly reactive molecules containing oxygen",
                "description": "Key players in oxidative stress, leading to lipid peroxidation and hydrocarbon emissions.",
                "findings": "Elevated ROS levels contribute to CRC pathogenesis and biomarker production.",
                "notes": "ROS are central to oxidative damage and are implicated in various cancers.",
                "knowledge": [
                    {
                        "predicate": "contribute to CRC pathogenesis",
                        "object": "Reactive Oxygen Species (ROS)"
                    }
                ]
            }
        },
        "sUFG-5gE": {
            "name": "T-antigen",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "T-antigen",
                "type": "glycoproteome/glycan",
                "description": "The T-antigen is an immature glycan signature found in stools, associated with abnormal glycosylation patterns.",
                "findings": "Stools from more aggressive lesions may exhibit abnormal immature glycan signatures not seen in healthy tissues. The T-antigen (core 1 glycans) is identified as a potential biomarker for non-invasive CRC screening.",
                "notes": "The T-antigen is specifically mentioned as part of core 1 glycans, which are associated with these abnormal signatures.",
                "knowledge": [
                    {
                        "predicate": "exhibit abnormal immature glycan signatures",
                        "object": "T-antigen"
                    },
                    {
                        "predicate": "identified as a potential biomarker for non-invasive CRC screening",
                        "object": "T-antigen"
                    }
                ]
            }
        },
        "zmEGWIho": {
            "name": "stool glycoproteome",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "deepseek-r1:70b-llama-distill-q8_0/KVUjX",
            "details": {
                "name": "stool glycoproteome",
                "type": "glycoproteome",
                "description": "The stool glycoproteome refers to the characterization of proteins and their glycan modifications found in stools.",
                "findings": "This work provides a characterization of the stool glycoproteome, identifying several molecular targets shared by more aggressive non-cancerous lesions and cancer.",
                "notes": "The study emphasizes the potential of these biomarkers for future pre-clinical assessment.",
                "knowledge": [
                    {
                        "predicate": "characterization of proteins and their glycan modifications found in stools",
                        "object": "stool glycoproteome"
                    },
                    {
                        "predicate": "identifying several molecular targets shared by more aggressive non-cancerous lesions and cancer",
                        "object": "stool glycoproteome"
                    }
                ]
            }
        }
    },
    "documents": {
        "10.1038/s41598-023-42037-w": {
            "doi": "10.1038/s41598-023-42037-w",
            "short_citation": "(Bao-Caamano;2023)",
            "long_citation": "Bao-Caamano, et al., Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer, , 2023"
        },
        "10.1002/anie.202306154": {
            "doi": "10.1002/anie.202306154",
            "short_citation": "(Saraei;2019)",
            "long_citation": "Saraei, et al., Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human Serum, , 2019"
        },
        "10.3390/cancers13184640": {
            "doi": "10.3390/cancers13184640",
            "short_citation": "(Dur\u00e1n-Vin;2021-09-16)",
            "long_citation": "Dur\u00e1n-Vin, et al., CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review, , 2021-09-16"
        },
        "10.3390/cancers16162796": {
            "doi": "10.3390/cancers16162796",
            "short_citation": "(Ashouri;2024-08-08)",
            "long_citation": "Ashouri, et al., Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review, , 2024-08-08"
        },
        "10.1126/sciadv.aaw1317": {
            "doi": "10.1126/sciadv.aaw1317",
            "short_citation": "(Carvalho;2024-12-04)",
            "long_citation": "Carvalho, et al., Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine, , 2024-12-04"
        },
        "10.1001/jamaoncol.2024.3891": {
            "doi": "10.1001/jamaoncol.2024.3891",
            "short_citation": "(Chen;2024-09-19)",
            "long_citation": "Chen, et al., Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer A Nonrandomized Clinical Trial, , 2024-09-19"
        },
        "10.1038/s42003-022-03249-4": {
            "doi": "10.1038/s42003-022-03249-4",
            "short_citation": "(Van Riet;1989)",
            "long_citation": "Van Riet, et al., CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue, , 1989"
        },
        "10.3390/ijms24010129": {
            "doi": "10.3390/ijms24010129",
            "short_citation": "(Chen;2022-12-21)",
            "long_citation": "Chen, et al., Diagnosis by Volatile Organic Compounds in Exhaled Breath from Patients with Gastric and Colorectal Cancers, , 2022-12-21"
        },
        "10.1111/j.2517-6161.1982.tb01195.x": {
            "doi": "10.1111/j.2517-6161.1982.tb01195.x",
            "short_citation": "(D'elia;1982)",
            "long_citation": "D'elia, et al., Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification, , 1982"
        },
        "10.1002/ijc.29701": {
            "doi": "10.1002/ijc.29701",
            "short_citation": "(Amal;2015)",
            "long_citation": "Amal, et al., Breath testing as potential colorectal cancer screening tool, , 2015"
        },
        "10.3390/ijms25073722": {
            "doi": "10.3390/ijms25073722",
            "short_citation": "(Kuppen;2024-03-27)",
            "long_citation": "Kuppen, et al., Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer, , 2024-03-27"
        }
    },
    "lang_info": {
        "deepseek-r1:70b-llama-distill-q8_0/KVUjX": {
            "llm_tag": "deepseek-r1:70b-llama-distill-q8_0",
            "prompt_template": "[BEGIN ARTICLE]:<content></content>\n[END ARTICLE]\n\n[INSTRUCTIONS]\nGenerate list of biomarkers that are topic of the article and for each such biomarker extract name, description, type, findings explicitly mentioned in the article, list of knowledge that consist of 'predicate' about the finding from findings and 'object' which biomarker is subject and related via 'predicate'.\nReturn the response in strict JSON format with the following structure:\n\n[\n  { \"name\": \"biomarker name\",\"type\":\"biomarker type\",\"description\":\"biomarker description\",\"findings\":\"findings about biomarker in article\",\"notes\":\"additional notes important to biomarker\", \"knowledge\":[{'predicate':'some predicate from findings of biomarker','object':'object that relates via predicate to the biomarker' }],\n  { \"name\": \"biomarker2 name\",\"type\":\"biomarker2 type\",\"description\":\"biomarker2 description\",\"findings\":\"findings about biomarker2 in article\",\"notes\":\"additional notes important to biomarker2\", \"knowledge\":[{'predicate':'some predicate from findings of  biomarker2','object':'object that relates via predicate to the biomarker2' }] }\n] \n\nEnsure there is no additional explanation, only return valid JSON.\n"
        }
    }
}